Our team

Dr. Xie is the Founder and President of Healsan, a leading company specializing in Healsan™ Big Data Analysis that drives innovation and facilitates the translation of outcomes in clinical research. Under his leadership, Healsan™ conducts over 300 medical big data analyses annually, providing insights into research trends and assessments of institutions, personnel, and sub-specialties to physician-scientists and hospitals.

As an alumnus of the prestigious Peking Union Medical College, Dr. Xie brings significant clinical and research expertise in the fields of neurology and autoimmunity. He spearheaded the development of the "Quantitative Assessment System for Scholars' Academic Contributions Based on Bibliometric Analysis," a cornerstone project for Healsan.

Dr. Xie has published over 100 peer-reviewed articles and has extensive experience in conducting or overseeing thousands of medical big data analyses, showcasing his deep understanding and significant achievements in research topics based on big data analysis within clinical research.

Before founding Healsan, Dr. Xie, a physician-scientist and neurologist, as well as a Principal Investigator, led initiatives funded by renowned institutions, including the National Natural Science Foundation and the Beijing Natural Science Foundation.

Dr. Liu led the development of the HansonCR™ system, which efficiently integrates and drafts scholarly research reviews, including those used to demonstrate eligibility for committee memberships or for Chinese doctors seeking U.S. National Interest or Extraordinary Ability Green Cards.

Dr. Liu graduated from Peking Union Medical College and formerly served as the Section Chief, Chief Physician, and Master’s Supervisor at Peking Union Medical College/Cancer Hospital, Chinese Academy of Medical Sciences.

 Dr. Liu has overseen projects funded by the National Natural Science Foundation of China and has conducted significant research on molecular markers for gastrointestinal tumors and the mechanisms of tumor pathogenesis. He also boasts extensive experience in surgical outcome research and the application of clinical databases. With over 100 peer-reviewed publications in this field and more than 2,000 citations, Dr. Liu has served as an editorial board member and reviewer for prestigious international journals. Additionally, he is an International Fellow in a renowned American professional association. 

 As the leader of the MedEditing™ team, Sean provides comprehensive support, specializing in Medical English training, academic manuscript editing, and meticulous revision of application materials. With a unique capability to evaluate completed green card applications from the perspective of an immigration officer, Sean produces detailed mock review reports that assess clarity, sufficiency of evidence, and likelihood of approval, significantly contributing to our team's outstanding 95% success rate for NIW and EB-1A cases.

Sean holds a Bachelor's degree in Education from the UK and brings over six years of English teaching experience, complemented by more than two years of specialized experience reviewing preliminary green card application materials. Throughout his extensive teaching career in China, Sean has developed notable expertise in Medical English and refined his skills in editing scholarly papers written by Chinese medical professionals.

Jessica is an integral member of our team as a Project Manager in the Green Card Application department. Not only does she provide free consultations to over 400 doctors and life scientists each year, but she is also responsible for overseeing the entire application process for hundreds of NIW and EB-1A cases, ensuring the smooth progression of applications.

In addition to her primary role, Jessica excels as the New Media Operations Manager. Her responsibilities include managing seven public WeChat accounts and two Rednote accounts.

  Tianyu Wang, a Master’s degree holder from Shanghai Jiao Tong University, is a distinguished clinical research professional with specialized expertise in clinical writing and medical big data analysis. Her meticulous attention to detail and fervent passion for research have culminated in several high-impact publications in prestigious journals. Proficient in machine learning, she leverages her profound expertise in clinical research to develop the Healsan medical big data analytics tool. Her capabilities in both traditional research methodologies and cutting-edge technologies bolster her capacity to thrive in a research-intensive environment. 

Angela graduated from Peking Union Medical College and brings over 20 years of experience in surgery and laboratory work. Her profound insights into clinical research, coupled with her excellent service skills and strong management capabilities, have greatly contributed to her professional stature. Having worked in Beijing, Hong Kong, and Vancouver, Angela possesses an exceptional international perspective and outstanding communication skills.

As the Director of Medical Big Data Analysis at Healsan, Angela provides data analytics to physician-scientist, and biopharmaceutical companies.

Iris Zhang is a dedicated B.S. Community Health student who is passionate about applying academic knowledge and research experience to tackle real-world challenges. Bilingual in Mandarin and English, she brings strong analytical and interpersonal skills to every opportunity, along with a dependable, adaptable, and hard-working approach. Iris is eager to contribute to the success of our organization and embrace new challenges that promote both professional growth and meaningful impact. 

Dr. Reyes developed a career emphasis on tumor immunology during post-graduate training at Yale University and went on to earn MD and PhD degrees from the University of Texas Health Science Center in San Antonio. His research has been published in top cancer immunotherapy journals and led to international collaborations with scientists at industry leading companies such as AstraZeneca and Janssen Pharmaceuticals. He is currently a physician-scientist in the Department of Medicine at the Washington University in St. Louis School of Medicine. 

Dr. Zhou is Director of the Center for Alzheimer Research at the Washington Institute of Clinical Research (WICRe) and Founder and CEO of AstraNeura. Using his medical expertise and PhD training in biochemistry, Dr. Zhou’s career emphasis has been on drug discovery and entrepreneurship. With more than 20 years of industry experience, Dr. Zhou has led drug discovery and development programs for small molecule therapeutics in oncology and central nervous system (CNS) acting agents. He was part of the team that developed the first histone deacetylase inhibitor Zolinza, contributes to several clinical stage CNS drug development programs, and is an inventor for 3 issued patents. 

Lily Sun brings over eight years of expertise in financial management to her role as CFO. She excels in budgeting, financial analysis, cost control, and tax planning, providing a solid foundation for robust financial governance. Liying is proficient in navigating complex financial systems and regulations. She has a sharp ability to interpret data and devise strategies that optimize corporate financial performance.

Known for her meticulous attention to detail and strong problem-solving skills, Liying thrives in dynamic and fast-paced environments.